chloroquine has been researched along with Muscle Disorders in 68 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pathological and biochemical observations are presented in a 55-year-old woman with lupus erythematosus and thymoma who developed a vacuolar myopathy while being treated with chloroquine." | 7.65 | Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle. ( Beveridge, B; Dawkins, RL; Mastaglia, FL; Papadimitriou, JM, 1977) |
| "Pathological and biochemical observations are presented in a 55-year-old woman with lupus erythematosus and thymoma who developed a vacuolar myopathy while being treated with chloroquine." | 3.65 | Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle. ( Beveridge, B; Dawkins, RL; Mastaglia, FL; Papadimitriou, JM, 1977) |
| "Chloroquine (CQ) is an antimalarial drug with a growing number of applications as recently demonstrated in attempts to treat Covid-19." | 1.91 | Molecular mechanisms in chloroquine-exposed muscle cells elucidated by combined proteomic and microscopic studies. ( Czech, A; Freier, E; Hathazi, D; Phan, V; Preuße, C; Roos, A; Shema, G; Zahedi, RP, 2023) |
| "Several myopathies are associated with defects in autophagic and lysosomal degradation of glycogen, but it remains unclear how glycogen is targeted to the lysosome and what significance this process has for muscle cells." | 1.39 | Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy. ( Nieuwenhuis, J; Perrimon, N; Zirin, J, 2013) |
| "Since 1989, she had been suffering from systemic lupus erythematosus (SLE) with renal involvement and undergone periods of treatment with azathioprine and cyclophosphamide." | 1.32 | Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus. ( Becker, A; Neuen-Jacob, E; Ostendorf, B; Richter, JG; Schneider, M; Specker, C; Stoll, G, 2003) |
| " In this study, we established experimental myopathy in hamsters by long-term administration of chloroquine, and we examined the nature of the PrP molecules that accumulated." | 1.32 | Accumulation of prion protein in muscle fibers of experimental chloroquine myopathy: in vivo model for deposition of prion protein in non-neuronal tissues. ( Doh-ura, K; Furukawa, H; Iwaki, T; Sasaki, K, 2004) |
| "With chloroquine treatment, muscle atrophy occurred predominantly in soleus muscle and unusual autophagosomes were accumulated." | 1.31 | The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy. ( Ishiura, S; Nakagawa, M; Nishino, I; Nonaka, I; Ohsumi, Y; Sasagawa, N; Suzuki, T; Yoshikawa, A; Yoshimori, T, 2002) |
| "A young woman on chronic corticosteroid treatment for systemic lupus erythematosus developed a myasthenia-like syndrome 7 weeks after starting chloroquine therapy." | 1.27 | Chloroquine myopathy and myasthenia-like syndrome. ( Cornelio, F; Mantegazza, R; Mora, M; Pareyson, D; Sghirlanzoni, A, 1988) |
| "Chloroquine is a neuromyotoxin that affects nerves and cardiac and skeletal muscles." | 1.27 | Chloroquine neuromyotoxicity. Clinical and pathologic perspective. ( Chou, SM; Estes, ML; Ewing-Wilson, D; Hanson, M; Mitsumoto, H; Ratliff, NB; Shirey, E, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (69.12) | 18.7374 |
| 1990's | 6 (8.82) | 18.2507 |
| 2000's | 10 (14.71) | 29.6817 |
| 2010's | 3 (4.41) | 24.3611 |
| 2020's | 2 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Phan, V | 1 |
| Hathazi, D | 1 |
| Preuße, C | 1 |
| Czech, A | 1 |
| Freier, E | 1 |
| Shema, G | 1 |
| Zahedi, RP | 1 |
| Roos, A | 1 |
| Guidon, AC | 1 |
| Amato, AA | 1 |
| Zirin, J | 2 |
| Nieuwenhuis, J | 2 |
| Perrimon, N | 2 |
| Samsonova, A | 1 |
| Tao, R | 1 |
| Kimura, N | 1 |
| Kumamoto, T | 6 |
| Oniki, T | 1 |
| Nomura, M | 1 |
| Nakamura, K | 2 |
| Abe, Y | 1 |
| Hazama, Y | 1 |
| Ueyama, H | 3 |
| Posada, C | 1 |
| García-Cruz, A | 1 |
| García-Doval, I | 1 |
| Millán, BS | 1 |
| Teijeira, S | 1 |
| Richter, JG | 1 |
| Becker, A | 1 |
| Ostendorf, B | 1 |
| Specker, C | 1 |
| Stoll, G | 1 |
| Neuen-Jacob, E | 1 |
| Schneider, M | 1 |
| Finsterer, J | 1 |
| Jarius, C | 1 |
| WHISNANT, JP | 1 |
| ESPINOSA, RE | 1 |
| KIERLAND, RR | 1 |
| LAMBERT, EH | 1 |
| SULLI, G | 1 |
| VARRONE, F | 1 |
| BEGG, TB | 1 |
| SIMPSON, JA | 1 |
| SPILLANE, JD | 1 |
| REWCASTLE, NB | 1 |
| HUMPHREY, JG | 1 |
| BLOM, S | 1 |
| LUNDBERG, PO | 1 |
| Furukawa, H | 1 |
| Doh-ura, K | 1 |
| Sasaki, K | 1 |
| Iwaki, T | 1 |
| Masuda, T | 1 |
| Jikumaru, M | 1 |
| Toyoshima, I | 2 |
| Casado, E | 1 |
| Gratacós, J | 1 |
| Tolosa, C | 1 |
| Martínez, JM | 1 |
| Ojanguren, I | 1 |
| Ariza, A | 1 |
| Real, J | 1 |
| Sanjuán, A | 1 |
| Larrosa, M | 1 |
| Ramos-Lázaro, J | 1 |
| de la Torre, N | 1 |
| Mateen, FJ | 1 |
| Keegan, BM | 1 |
| Sibrans, DF | 1 |
| Holley, HL | 1 |
| Araki, S | 2 |
| Fukuhara, N | 2 |
| Tsuzuki, K | 2 |
| Fukatsu, R | 2 |
| Takamaru, Y | 2 |
| Yoshida, T | 2 |
| Hayashi, Y | 2 |
| Yamaguchi, H | 1 |
| Fujii, N | 2 |
| Takahata, N | 2 |
| Kobayashi, K | 1 |
| Rabuñal Rey, R | 1 |
| Sánchez-Andrade, A | 1 |
| Navarro Fernández-Balbuena, C | 1 |
| Brañas Fernández, F | 1 |
| Nagao, SI | 1 |
| Sugihara, R | 1 |
| Abe, T | 1 |
| Tsuda, T | 1 |
| Murakami, N | 2 |
| Oyama, F | 2 |
| Gu, Y | 1 |
| McLennan, IS | 1 |
| Nonaka, I | 3 |
| Ihara, Y | 2 |
| Suzuki, T | 1 |
| Nakagawa, M | 1 |
| Yoshikawa, A | 1 |
| Sasagawa, N | 1 |
| Yoshimori, T | 1 |
| Ohsumi, Y | 1 |
| Nishino, I | 1 |
| Ishiura, S | 3 |
| Drenckhahn, D | 1 |
| Lüllmann-Rauch, R | 1 |
| Lhermitte, F | 1 |
| Marteau, R | 1 |
| Chedru, F | 1 |
| Mallecourt, J | 1 |
| Estrade, G | 1 |
| Godet-Guillain, J | 1 |
| Chevallay, M | 1 |
| Nordemar, R | 1 |
| Klinghardt, GW | 4 |
| Mastaglia, FL | 1 |
| Papadimitriou, JM | 1 |
| Dawkins, RL | 1 |
| Beveridge, B | 1 |
| Stauber, WT | 1 |
| Bird, JW | 1 |
| Schottelius, BA | 1 |
| Amir, M | 1 |
| Khan, KA | 1 |
| Ahmad, SH | 1 |
| Ionescu, M | 1 |
| Alexianu, M | 1 |
| Luca, N | 1 |
| Petrovici, A | 1 |
| Plăiaşu, D | 1 |
| Voiculescu, V | 1 |
| Watanabe, S | 1 |
| Ikebe, N | 1 |
| Higuchi, I | 2 |
| Ishihara, T | 1 |
| Sugita, H | 2 |
| Léger, JM | 1 |
| Puifoulloux, H | 1 |
| Dancea, S | 1 |
| Hauw, JJ | 1 |
| Bouche, P | 1 |
| Rougemont, D | 1 |
| Laplane, D | 1 |
| Sghirlanzoni, A | 1 |
| Mantegazza, R | 1 |
| Mora, M | 1 |
| Pareyson, D | 1 |
| Cornelio, F | 1 |
| Ii, K | 1 |
| Katunuma, N | 1 |
| Sano, M | 2 |
| Estes, ML | 1 |
| Ewing-Wilson, D | 1 |
| Chou, SM | 1 |
| Mitsumoto, H | 1 |
| Hanson, M | 1 |
| Shirey, E | 1 |
| Ratliff, NB | 1 |
| Macdonald, RD | 1 |
| Engel, AG | 1 |
| Hughes, JT | 1 |
| Esiri, M | 1 |
| Oxbury, JM | 1 |
| Whitty, CW | 1 |
| Roelofs, RI | 1 |
| Engel, WK | 1 |
| Man, HX | 1 |
| Millingen, KS | 1 |
| Suerth, E | 1 |
| Gleiser, CA | 1 |
| Bay, WW | 1 |
| Dukes, TW | 1 |
| Brown, RS | 1 |
| Read, WK | 1 |
| Pierce, KR | 1 |
| Hicklin, JA | 1 |
| Johansson, B | 1 |
| Schimrigk, K | 1 |
| Gérard, JM | 1 |
| Stoupel, N | 1 |
| Collier, A | 1 |
| Flament-Durand, J | 1 |
| Ebringer, A | 1 |
| Eadie, MJ | 1 |
| Ferrier, TM | 1 |
| Thomas, PK | 1 |
| Erringer, A | 1 |
| Colville, P | 1 |
| Kaeser, HE | 1 |
| Kocher, R | 1 |
| Weber, M | 1 |
| Brichet, B | 1 |
| Penin, F | 1 |
| Huriet, C | 1 |
| Tridon, P | 1 |
| Chapman, RS | 1 |
| Ewen, SW | 1 |
| Garcin, R | 1 |
| Rondot, P | 1 |
| Fardeau, M | 1 |
| Smith, B | 1 |
| O'Grady, F | 1 |
6 reviews available for chloroquine and Muscle Disorders
| Article | Year |
|---|---|
COVID-19 and neuromuscular disorders.
Topics: Antiviral Agents; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Delivery of Heal | 2020 |
[EXTRAMALARIAL THERAPUETIC APPLICATIONS OF ANTIMALARIAL DRUGS. 1. CLINICAL UTILIZATIONS].
Topics: Amodiaquine; Antimalarials; Chloroquine; Collagen Diseases; Dermatology; Drug Utilization; Epilepsy; | 1963 |
Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antimalarials; Brain; Chloroquine; Humans; Lysosomes; Muscles; Muscular | 1998 |
[Amphiphilic cationic drug myopathy, drug-induced lysosomal storage lipidosis].
Topics: Aminoquinolines; Amiodarone; Animals; Anti-Arrhythmia Agents; Antimalarials; Autophagy; Cations; Chl | 2001 |
Experimental neuropathology and clinical neurology of chloroquine side effects.
Topics: Animals; Axons; Chloroquine; Cytoplasmic Granules; Dose-Response Relationship, Drug; Ganglia, Spinal | 1978 |
[Side effects of drugs. 4. Drug induced polyneuropathies and myopathies].
Topics: Adrenocorticotropic Hormone; Chloroquine; Glucocorticoids; Humans; Hydralazine; Isoniazid; Muscular | 1969 |
62 other studies available for chloroquine and Muscle Disorders
| Article | Year |
|---|---|
Molecular mechanisms in chloroquine-exposed muscle cells elucidated by combined proteomic and microscopic studies.
Topics: Chloroquine; COVID-19; COVID-19 Drug Treatment; Humans; Muscle Cells; Muscular Diseases; Proteins; P | 2023 |
Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy.
Topics: Amino Acid Sequence; Animals; Autophagy; Catalytic Domain; Chloroquine; Drosophila melanogaster; Dro | 2013 |
Regulators of autophagosome formation in Drosophila muscles.
Topics: Animals; Autophagy; Cell Communication; Chloroquine; Drosophila melanogaster; Glycogen; GTPase-Activ | 2015 |
Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
Topics: Animals; Antimalarials; Chloroquine; Immunohistochemistry; Male; Muscle Denervation; Muscle Fibers, | 2009 |
Chloroquine-induced myopathy.
Topics: Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Lupus | 2011 |
Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus.
Topics: Antirheumatic Agents; Chloroquine; Creatine Kinase; Diagnosis, Differential; Female; Humans; Lupus E | 2003 |
Increased CSF protein in chloroquine-induced axonal polyneuropathy and myopathy.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis; Biopsy; Cerebrospinal Fluid Proteins; Chlo | 2003 |
CHLOROQUINE NEUROMYOPATHY.
Topics: Aspartate Aminotransferases; Blood Chemical Analysis; Chloroquine; Electromyography; Humans; Lupus E | 1963 |
CHLOROQUINE NEUROMYOPATHY.
Topics: Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Chloroquine; Muscular Diseases; Neuro | 1964 |
IATROGENIC NEUROLOGICAL DISEASES. DRUG-INDUCED NEUROLOGICAL DISORDERS.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antihypertensive Agents | 1964 |
VACUOLAR MYOPATHY: CLINICAL, HISTOCHEMICAL, AND MICROSCOPIC STUDY.
Topics: Aspartate Aminotransferases; Biopsy; Chloroquine; Drug Therapy; Electromyography; Histocytochemistry | 1965 |
REVERSIBLE MYOPATHY IN CHLOROQUINE TREATMENT.
Topics: Chloroquine; Electromyography; Humans; Muscular Diseases; Neurologic Examination; Toxicology | 1965 |
Accumulation of prion protein in muscle fibers of experimental chloroquine myopathy: in vivo model for deposition of prion protein in non-neuronal tissues.
Topics: Animals; Chloroquine; Cricetinae; Endopeptidase K; Female; Mesocricetus; Muscle Fibers, Skeletal; Mu | 2004 |
Skeletal muscle expression of clathrin and mannose 6-phosphate receptor in experimental chloroquine-induced myopathy.
Topics: Animals; Chloroquine; Clathrin; Gene Expression Regulation; Male; Muscle, Skeletal; Muscular Disease | 2005 |
Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients.
Topics: Adult; Aged; Antimalarials; Antirheumatic Agents; Biopsy; Chloroquine; Clinical Enzyme Tests; Electr | 2006 |
[Motor incapability in a patient with arthritis].
Topics: Antirheumatic Agents; Arthritis; Chloroquine; Diagnosis, Differential; Female; Humans; Middle Aged; | 2006 |
Severe, reversible dysphagia from chloroquine and hydroxychloroquine myopathy.
Topics: Aged, 80 and over; Antirheumatic Agents; Chloroquine; Deglutition Disorders; Humans; Hydroxychloroqu | 2007 |
Vacuolar myopathy in a patient with positive LE cell preparations.
Topics: Adult; Betamethasone; Chloroquine; Cytoplasm; Dexamethasone; Electromyography; Female; Humans; Lupus | 1967 |
[Experimental chloroquine myopathy--morphological and biochemical studies].
Topics: Animals; Chloroquine; Lysosomes; Mice; Muscle Proteins; Muscles; Muscular Diseases; Sarcoplasmic Ret | 1984 |
Amyloid beta protein in rat soleus muscle in chloroquine-induced myopathy using end-specific antibodies for A beta 40 and A beta 42: immunohistochemical evidence for amyloid beta protein.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antibodies, Monoclonal; Antibody Spe | 1995 |
Snake coiled fibres in rat soleus muscle in chloroquine induced myopathy share immunohistochemical characteristics with amyloid depositions in Alzheimer's disease brain tissue.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Chloroquine; Disease Mod | 1997 |
[myotoxicity by chloroquine: report of a case].
Topics: Aged; Antirheumatic Agents; Chloroquine; Female; Humans; Muscular Diseases | 1997 |
Effect of chloroquine-induced myopathy on rat soleus muscle sarcoplasm and expression of clathrin.
Topics: Animals; Blotting, Western; Chloroquine; Clathrin; Immunoblotting; Muscle Denervation; Muscle, Skele | 1998 |
Accumulation of tau in autophagic vacuoles in chloroquine myopathy.
Topics: Acid Phosphatase; Amyloid beta-Protein Precursor; Animals; Autophagy; Chloroquine; Gene Expression R | 1998 |
The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy.
Topics: Animals; Autophagy; Blotting, Western; Chloroquine; COS Cells; Disease Models, Animal; Dose-Response | 2002 |
Experimental myopathy induced by amphiphilic cationic compounds including several psychotropic drugs.
Topics: Amitriptyline; Animals; Chloroquine; Chlorphentermine; Chlorpromazine; Female; Imipramine; Iprindole | 1979 |
[Chloroquine neuromyopathy. One case in prophylactic maleriatherapy (author's transl)].
Topics: Adult; Chloroquine; Humans; Malaria; Male; Muscles; Muscular Diseases; Peripheral Nervous System Dis | 1977 |
[Muscular changes in rheumatoid arthritis and other rheumatic disorders].
Topics: Arthritis, Rheumatoid; Chloroquine; Humans; Muscles; Muscular Diseases; Penicillamine; Rheumatic Dis | 1979 |
Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle.
Topics: Animals; Chloroquine; Female; Histocytochemistry; Humans; Lipid Metabolism; Lipofuscin; Lupus Erythe | 1977 |
Catalase: an enzymatic indicator of the degree of muscle wasting.
Topics: Acid Phosphatase; Animals; Arylsulfatases; Back; Catalase; Cathepsins; Chickens; Chloroquine; Glucur | 1977 |
Siquil dystonia nd chloroquin.
Topics: Child; Child, Preschool; Chloroquine; Drug Synergism; Female; Humans; Male; Muscle Tonus; Muscular D | 1976 |
Chloroquine myopathy.
Topics: Chloroquine; Female; Humans; Middle Aged; Muscles; Muscular Diseases | 1975 |
Experimental chloroquine myopathy: morphological and biochemical studies.
Topics: Animals; Chloroquine; Leucine; Male; Microscopy, Electron; Muscular Diseases; Rats; Rats, Inbred Str | 1989 |
High AMP deaminase activity in rimmed vacuoles of skeletal muscle.
Topics: Acid Phosphatase; Adenosine Triphosphatases; Adult; AMP Deaminase; Animals; Chloroquine; Female; Glu | 1986 |
[Chloroquine neuromyopathies: 4 cases during antimalarial prevention].
Topics: Adult; Chloroquine; Humans; Hypesthesia; Inclusion Bodies; Microscopy, Electron; Movement Disorders; | 1986 |
Chloroquine myopathy and myasthenia-like syndrome.
Topics: Adult; Biopsy; Chloroquine; Female; Humans; Lupus Erythematosus, Systemic; Microscopy, Electron; Mus | 1988 |
[The therapeutic effect of cysteine proteinase inhibitor, EST, on experimental chloroquine myopathy].
Topics: Animals; Chloroquine; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Muscular Disease | 1986 |
[Biochemical studies in experimental chloroquine myopathy--preventive effect of E-64-d and physicochemical properties of liver autolysosomes].
Topics: Animals; Cathepsins; Chloroquine; Leucine; Liver; Lysosomes; Male; Muscular Diseases; Rats; Rats, In | 1986 |
Chloroquine neuromyotoxicity. Clinical and pathologic perspective.
Topics: Aged; Biopsy; Cardiomyopathies; Chloroquine; Female; Humans; Hydroxychloroquine; Male; Middle Aged; | 1987 |
[Biochemical studies on experimental chloroquine myopathy].
Topics: Animals; Chloroquine; Disease Models, Animal; Lysosomes; Male; Microscopy, Electron; Muscle Proteins | 1985 |
[Experimental lesions of the nervous and muscular systems due to chloroquine: models of various storage dystrophies (author's transl)].
Topics: Animals; Chloroquine; Chromatography, Thin Layer; Disease Models, Animal; Germ-Free Life; Glycogen S | 1974 |
[Experimental studies on the etiology of nitrofurane-induced polyneuropathy and histopathology of chlorochindiphosphate (Resochin) neuro-myopathy].
Topics: Animals; Chloroquine; Disease Models, Animal; Muscle Spindles; Muscular Diseases; Nitrofurans; Polyn | 1970 |
Experimental chloroquine myopathy.
Topics: Acid Phosphatase; Adenosine Triphosphatases; Animals; Biopsy; Chloroquine; Female; Histocytochemistr | 1970 |
Chloroquine myopathy.
Topics: Adenosine Triphosphatases; Arthritis, Rheumatoid; Autopsy; Chloroquine; Female; Histocytochemistry; | 1971 |
Myopathies associated with systemic diseases.
Topics: Alcoholism; Anti-Bacterial Agents; Chloroquine; Collagen Diseases; Endocrine System Diseases; Erythe | 1971 |
[Apropos of 2 cases of ocular and neuromuscular complications seen during prolonged treatment with chloroquine].
Topics: Chloroquine; Female; Humans; Middle Aged; Muscular Diseases; Peripheral Nervous System Diseases; Ret | 1965 |
Peripheral neuromyopathy following chloroquine therapy.
Topics: Adult; Chloroquine; Female; Humans; Lupus Erythematosus, Discoid; Muscular Diseases; Peripheral Nerv | 1966 |
Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine.
Topics: Animals; Arteries; Bone Marrow; Central Nervous System; Central Nervous System Diseases; Chloroquine | 1968 |
Chloroquine neuromyopathy.
Topics: Aged; Arthritis, Rheumatoid; Chloroquine; Electromyography; Female; Humans; Lupus Erythematosus, Sys | 1968 |
[Histopathologic peculiarities of the myoneuropathy caused by chloroquine diphosphate].
Topics: Animals; Chloroquine; Glucosyltransferases; Histocytochemistry; L-Lactate Dehydrogenase; Models, Bio | 1968 |
[Clinical aspects and therapy of metabolic and other symptomatic muscular diseases].
Topics: Acromegaly; Addison Disease; Adolescent; Adrenal Cortex Hormones; Chloroquine; Cushing Syndrome; Ele | 1972 |
Morphologic study of a neuromyopathy caused by prolonged chloroquine treatment.
Topics: Action Potentials; Chloroquine; Electromyography; Female; Humans; Lupus Erythematosus, Discoid; Micr | 1973 |
Chloroquine myopathy.
Topics: Arthritis, Rheumatoid; Blindness; Chloroquine; Cornea; Female; Humans; Muscular Diseases; Retina | 1971 |
Chloroquine myopathy.
Topics: Adult; Chloroquine; Electromyography; Female; Glycogen Storage Disease; Humans; Male; Middle Aged; M | 1966 |
Myopathy.
Topics: Alcoholism; Chloroquine; Glucosyltransferases; Glycogen Storage Disease; Humans; Ischemia; Muscular | 1970 |
Chloroquine neuromyopathy associated with keratopathy and retinopathy.
Topics: Chloroquine; Corneal Dystrophies, Hereditary; Eye Diseases; Female; Humans; Middle Aged; Muscular Di | 1967 |
[Iatrogenic muscular symptoms and myopathies].
Topics: Chloroquine; Glucocorticoids; Humans; Iatrogenic Disease; Muscular Diseases; Time Factors | 1970 |
Chloroquine myopathy.
Topics: Arthritis, Rheumatoid; Chloroquine; Female; Humans; Mitochondria, Muscle; Muscular Diseases; Sarcoid | 1971 |
[Electromyography and chloroquine-induced neuromyopathy].
Topics: Adult; Chloroquine; Electromyography; Humans; Male; Muscles; Muscular Diseases; Neuromuscular Juncti | 1968 |
Chloroquine-induced myopathy.
Topics: Chloroquine; Electromyography; Female; Histocytochemistry; Humans; Middle Aged; Muscular Diseases; P | 1969 |
[Note on the development of muscular lesions observed during prolonged chloroquine treatment, after cessation of the drug].
Topics: Chloroquine; In Vitro Techniques; Muscular Diseases | 1965 |
Experimental chloroquine myopathy.
Topics: Animals; Chloroquine; Muscular Diseases; Rabbits | 1966 |